With lots of devices in development -- including transseptal devices Sapien M3, HighLife Valve, Cephea, Intrepid, and ...

In this interview, Dr. Fu Wei, Director of Quality Management Department at BGI Genomics talks to AZoMedical about achieving and maintaining ISO/IEC 27001 and BS 10012 certifications. Isaac ...

The new paper sums up the basics for clinicians who are starting to use 3D intracardiac echo, with an eye toward the future.

May 8, 2024 /PRNewswire/ -- Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, announces the launch of CARTO ™ 3 System Version 8 ...

"The breadth of data presented by Biosense Webster at this year's meeting underscores our commitment advancement of knowledge and innovation in the treatment of cardiac arrhythmias." AFib is ...

Johnson & Johnson announced it has completed its acquisition of Shockwave Medical. Shockwave is now part of Johnson & Johns ...

Paid and presented by Biosense Webster. Atrial fibrillation (AFib) is fast becoming one of the world’s most significant health issues, affecting millions worldwide, but it is also one of the ...

"Johnson & Johnson acquires Shockwave in $13.1bn deal" was originally created and published by Medical Device Network, a ...

Mika Pettersson from the University of Jyväskylä and Dr. Ivan Bobrinetskiy from the Biosense Institute highlight ultrafast laser processing of 2D materials as an efficient technique for fabricating 2D ...

Secondary analysis of the pivotal ADVENT trial showed that PFA with the Farawave device was actually superior in one respect ...

Johnson & Johnson today announced it completed its $13.1 billion acquisition of Shockwave Medical and its intravascular ...